CareMax (CMAX) Misses Q3 EPS by 17c, Revenue Beats, Offers Guidance

CareMax (NASDAQ: CMAX) reported Q3 EPS of ($0.25), $0.17 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $157.7 million versus the consensus estimate of $141.28 million.

GUIDANCE:

CareMax sees FY2022 revenue of $600-620 million, versus the consensus of $595 million.

For earnings history and earnings-related data on CareMax (CMAX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c